Geneva, May 18 -- International Clinical Trials Registry received information related to the study (ChiCTR2600124217) titled 'The efficacy and safety of paliperidone palmitate injection(II) as a replacement for oral medication in the treatment of schizophrenia' on May 8.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Nanjing Brain Hospital
Condition:
schizophrenia
Intervention:
observation group:Palmitone Palmitate Injection (II) Medication Method: On the first day of treatment, the patient is injected with 351 mg of this product at the deltoid muscle site. After the initial administration, the medication should be given once a month. Depending on the patient's tolerance and/or efficacy, the monthly inj...